Cephalon sues Watson for generic version of Nuvigil
Cephalon sues Watson for generic version of Nuvigil | 
Last Wednesday, Cephalon Inc. formally announced that it is suing Watson Pharmaceuticals Inc. for developing a generic version of Nuvigil, Cephalon’s sleep disorder drug.
Cephalon has also filed a similar lawsuit against Teva Pharmaceutical Industries Ltd. The two companies will also be disputing over the sleep disorder drug.
In recent years, Cephalon had settled patent disputes with several companies, including Teva and Watson.
The latest lawsuit was triggered by Watson’s Food and Drug Administration (FDA) request for approval on a generic version of Nuvigil. Cephalon’s suit with Watson will trigger a mandatory waiting period to prevent the FDA from approving the generic version of Nuvigil for 30 months, or until the court makes a ruling.
Source: ABC News
You must be logged in to post a comment.
Latest Headlines
- Link between insomnia and death is still not proven
- First NY Professional Sleep Medicine Conference To Be Held in Albany, NY Oct. 1-2, 2010: Medical Reporters Welcome
- More military vets suffer from sleep apnea
- Sleep Apnea Group, SleepSafe Driver, Hires John Hill As Senior Advisor
- Insomnia linked to premature death in men
- British Association for Psychopharmacology releases treatment guidelines for sleep disorders
- Sleep Insights opens new sleep center
- Continucare acquires sleep diagnostic center
- NorthBay Healthcare holds sleep lecture
- New mothers get enough sleep, just not good-quality sleep
- Vaccine linked to Narcolepsy
- New sleep apnea research reported from University of California, Department of Psychiatry
- Sleep Apnea Revealed website adds new content on Sleep Apnea Surgery
- New drug combats jet lag
- The Best Sleep Apnea Treatment: CPAP vs. Oral Appliances: A Question of Compliance and Effectiveness
In The News
Helping Australia Sleep—new sleep lab in Gold Coast
A doctor based in Queensland’s Gold
Sleep Group Solutions, Glidewell Laboratories Partner to Provide Education About Snoring/Sleep Apnea Preventive Care
[PRWEB] — Sleep Group Solutions (SGS)
Australian doctors link obesity to sleep disorders
Researchers recently reviewed the records of
Cephalon sues Apotex for sleep drug patent
Cephalon Inc. is suing Apotex Corp.